Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small...
Q1 2026
May 7, 2026
FY 2025
Mar 4, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 7, 2025